Skip to content
HPB wrapped 2025
*
1.
Pick your top 10 best studies for HPB surgical oncology in 2024, in the following list (click on the links to access the publications):
(Required.)
The Impact of KRAS Status on Long-Term Outcomes After Thermal Ablation and Hepatic Resection for Liver-Only Colorectal Metastases: A New Clue for Tailoring Surgical Strategy on Tumor Biology?
PREHEP trial
- Prehabilitation With Exercise and Nutrition to Reduce Morbidity of Major Hepatectomy in Patients With Sarcopenia
AIO/CALGP/ACO-GAIN-Trial
- Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone followed adjuvant therapy in biliary tract cancer
TESLA 1
- Primary percutaneous stenting above the ampulla versus endoscopic drainage for unresectable malignant hilar biliary obstruction
Adjuvant Chemoradiation and Immunotherapy for Extrahepatic Cholangiocarcinoma and Gallbladder Cancer
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy
Results of a randomized phase III trial of pre-operative chemotherapy with mFOLFIRINOX or PAXG regimen for stage I-III pancreatic ductal adenocarcinoma.
PACYFIC tria
l - Small and Stable Pancreatic Cysts Are Reassuring During Surveillance:
PREOPANC 2
- Neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy in resectable and borderline resectable pancreatic cancer
COLLISION
- Thermal ablation versus surgical resection of small-size colorectal liver metastases
ENDURO
- Endoscopic versus surgical gastroenterostomy for palliation of malignant gastric outlet obstruction
AROD
- Assessment of Residual or Resected Disappearing Liver Metastases After Chemotherapy
ROCNROLL
- Robotic versus laparoscopic hepatectomy for liver malignancies
Personalized Surveillance Intervals for Intraductal Papillary Mucinous Neoplasm (IPMN): Multicenter Study Using Parametric Models
PANDRA-II
- Reconsidering Abdominal Drainage After Left Pancreatectomy
Defining Biological Borderline Resectable Non-functioning Pancreatic Neuroendocrine Tumors
JSAP05
- Neoadjuvant Chemotherapy with Gemcitabine and S-1 versus Upfront Surgery for Resectable Pancreatic Cancer
Impact of pre-compression versus non-compression before parenchyma transection in left-sided pancreatic resection on the rate of clinically relevant pancreatic fistula: multicentre randomized clinical trial
PRODIGE 29-UCGI 26 (NEOPAN)
: A Phase III Randomized Trial Comparing Chemotherapy With FOLFIRINOX or Gemcitabine in Locally Advanced Pancreatic Carcinoma
Nonoperative Management of Technically Resectable Pancreatic Cancer With Ablative Radiation Therapy
Best Practices for Delivering Neoadjuvant Therapy in Pancreatic Ductal Adenocarcinoma
PRICE2
- Hypovolaemic phlebotomy in patients undergoing hepatic resection at higher risk of blood loss
Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer